Nuvation Bio Inc.

NUVB · NYSE
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$567,939-$75,802-$104,199-$86,848
Dep. & Amort.$683$222$199$184
Deferred Tax$0$0$0$0
Stock-Based Comp.$32,275$19,513$16,292$9,268
Change in WC-$12,507$540-$3,447$4,793
Other Non-Cash$417,075-$12,472-$4,953$4,413
Operating Cash Flow-$130,413-$67,999-$96,108-$68,190
Investing Activities
PP&E Inv.-$162-$69-$370-$282
Net Acquisitions$12,428$0$0$0
Inv. Purchases$0-$703,373-$520,307-$609,300
Inv. Sales/Matur.$0$712,349$584,121$154,913
Other Inv. Act.$110,437$14$13$0
Investing Cash Flow$122,703$8,921$63,457-$454,669
Financing Activities
Debt Repay.-$4,554$0$0$0
Stock Issued$4,885$0$0$0
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$628$1,327$625,527
Financing Cash Flow$331$628$1,327$625,527
Forex Effect$453$0$0$0
Net Chg. in Cash-$6,926-$58,450-$31,324$102,668
Supplemental Information
Beg. Cash$42,649$101,099$132,423$29,755
End Cash$35,723$42,649$101,099$132,423
Free Cash Flow-$130,575-$68,068-$96,478-$68,472
Nuvation Bio Inc. (NUVB) Financial Statements & Key Stats | AlphaPilot